The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cyclosporin versus tacrolimus for liver transplanted patients
Open accessAbstract
BACKGROUND: Most liver transplant recipients receive either cyclosporin or tacrolimus to prevent rejection. Both drugs inhibit calcineurin phosphatase which is thought to be the mechanism of their anti-rejection effect and principle toxicities. The drugs have different pharmacokinetic profiles and potencies. Several randomised clinical trials have compared cyclosporin and tacrolimus in liver transplant recipients, but it remains unclear which is superior. OBJECTIVES: To evaluate the beneficial and harmful effects of immunosuppression with cyclosporin versus tacrolimus for liver transplanted patients. SEARCH STRATEGY: The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials in The Cochrane Library, MEDLINE, EMBASE, and Science Citation Index Expanded, and conference proceedings were searched (August 2005) to identify relevant randomised clinical trials. Our search included scanning of reference lists in relevant articles and correspondence with investigators and pharmaceutical companies. SELECTION CRITERIA: All randomised clinical trials where tacrolimus was compared with cyclosporin for the initial treatment of first-time liver transplant recipients. We included randomised trials irrespective of blinding, language, and publication status. DATA COLLECTION AND ANALYSIS: The primary outcome measure was all-cause mortality. Data were synthesised (fixed-effect model) and results expressed as relative risk (RR), values less than 1.0 favouring tacrolimus, with 95% confidence intervals (CI). Two authors assessed trials for eligibility, quality, and extracted data independently. MAIN RESULTS: We included 16 randomised trials. The number of deaths was 254 in the tacrolimus group (1899 patients) and 302 in the cyclosporin group (1914 patients). At one year, mortality (RR 0.85, 95% CI 0.73 to 0.99) and graft loss (RR 0.73, 95% CI 0.61 to 0.86) were significantly reduced in tacrolimus-treated recipients. Tacrolimus reduced the number of recipients with acute rejection (RR 0.81, 95% CI 0.75 to 0.88), and steroid-resistant rejection (RR 0.54, 95% CI 0.47 to 0.74) in the first year. Differences were not seen with respect to lymphoproliferative disorder or de-novo dialysis rates, but more de-novo insulin-requiring diabetes mellitus (RR 1.38, 95% CI 1.01 to 1.86) occurred in the tacrolimus group. More patients were withdrawn from cyclosporin therapy than from tacrolimus (RR 0.57, 95% CI 0.49 to 0.66). AUTHORS' CONCLUSIONS: Tacrolimus is superior to cyclosporin in improving survival (patient and graft) and preventing acute rejection after liver transplantation, but it increases the risk of post-transplant diabetes. Treating 100 recipients with tacrolimus instead of cyclosporin would avoid acute rejection and steroid-resistant rejection in nine and seven patients, respectively, and graft loss and death in five and two patients, respectively, but four additional patients would develop diabetes after liver transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kjaergard, L. L., Villumsen, J., & Gluud, C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00010 · Cited by 2,283
A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation
(1994) · New England Journal of Medicine · doi:10.1056/nejm199410273311702 · Cited by 920
Royle, P., & Milne, R. (2003) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462303000552 · Cited by 693
(1994) · The Lancet · doi:10.1016/s0140-6736(94)91766-3 · Cited by 656
Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients
Webster, A. C., Taylor, R. R., Chapman, J. R., & Craig, J. C. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003961.pub2 · Cited by 286
Knoll, G. A., & Bell, R. C. (1999) · BMJ · doi:10.1136/bmj.318.7191.1104 · Cited by 263
O'Grady, J., Burroughs, A., Hardy, P., Elbourne, D., & Truesdale, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11196-2 · Cited by 259
Levy, G. A., Villamil, F. G., Samuel, D., San-Juan, F., Grazi, G. L., Wu, Y., Marotta, P., Boillot, O., Muehlbacher, F., & Klintmalm, G. B. (2004) · Transplantation · doi:10.1097/01.tp.0000129095.51031.42 · Cited by 137
PREDNISONE WITHDRAWAL 14 DAYS AFTER LIVER TRANSPLANTATION WITH MYCOPHENOLATE
Stegall, M. D., Wachs, M. E., Everson, G. T., Steinberg, T. G., Bilir, B. M., Shrestha, R., Karrer, F. M., & Kam, I. (1997) · Transplantation · doi:10.1097/00007890-199712270-00023 · Cited by 132
Fung, J. J., Abu-Elmagd, K., Jain, A. B., Gordon, R., Tzakis, A. G., Todo, S., Takaya, S., Alessiani, M., Demetris, A., & Bronster, O. (1991) · PubMed · Cited by 132
Cited by
TFOS DEWS II Management and Therapy Report
Jones, L., Downie, L. E., Korb, D., Benitez-del-Castillo, J. M., Dana, R., Deng, S. X., Dong, P. N., Geerling, G., Hida, R. Y., Liu, Y., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.006 · Cited by 1,422
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
Soares, R. O. S., Losada, D. M., Jordani, M. C., Évora, P., & Castro-e-Silva, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205034 · Cited by 408
McAlister, V. C., Haddad, E., Renouf, E., Malthaner, R. A., Kjaer, M. S., & Gluud, L. L. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01360.x · Cited by 263
Self-citationA comprehensive review of immunosuppression used for liver transplantation
Mukherjee, S., & Mukherjee, U. (2009) · Journal of Transplantation · doi:10.1155/2009/701464 · Cited by 140
Metadata
- Authors
- Haddad, E., McAlister, V., Renouf, E., Malthaner, R., Kjaer, M. S., & Gluud, L. L.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2006-10-18
- Volume
- 2010
- Issue
- 1
- Pages
- CD005161-CD005161
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2127746188
- Cited by
- 259
- References
- 23
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclosporin versus tacrolimus for liver transplanted patients. https://app.cochat.ai/papers/10.1002/14651858.cd005161.pub2
- The paper
- Haddad, E., McAlister, V., Renouf, E., Malthaner, R., Kjaer, M. S., & Gluud, L. L. (2006). Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd005161.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.